Defunct Company
Total Trials
1
As Lead Sponsor
0
As Collaborator
Total Enrollment
5,000
NCT04684602
Mesenchymal Stem Cells for the Treatment of Various Chronic and Acute Conditions
Phase: Phase 1/2
Role: Collaborator
Start: Jul 9, 2020
Completion: Dec 9, 2030